Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.

Labori KJ, Bratlie SO, Andersson B, Angelsen JH, Biörserud C, Björnsson B, Bringeland EA, Elander N, Garresori H, Grønbech JE, Haux J, Hemmingsson O, Liljefors MG, Myklebust TÅ, Nymo LS, Peltola K, Pfeiffer P, Sallinen V, Sandström P, Sparrelid E, Stenvold H, Søreide K, Tingstedt B, Verbeke C, Öhlund D, Klint L, Dueland S, Lassen K, Nordic Pancreatic Cancer Trial-1 study group

Open source

DOI: 10.1016/s2468-1253(23)00405-3
Published: 2024 Mar
Container: The lancet. Gastroenterology & hepatology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2468-1253-23-00405-3,
  title = {Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.},
  author = {Labori KJ and Bratlie SO and Andersson B and Angelsen JH and Biörserud C and Björnsson B and Bringeland EA and Elander N and Garresori H and Grønbech JE and Haux J and Hemmingsson O and Liljefors MG and Myklebust TÅ and Nymo LS and Peltola K and Pfeiffer P and Sallinen V and Sandström P and Sparrelid E and Stenvold H and Søreide K and Tingstedt B and Verbeke C and Öhlund D and Klint L and Dueland S and Lassen K and Nordic Pancreatic Cancer Trial-1 study group},
  year = {2024},
  journal = {The lancet. Gastroenterology \& hepatology},
  doi = {10.1016/s2468-1253(23)00405-3},
  url = {https://doi.org/10.1016/s2468-1253(23)00405-3}
}

RIS

TY  - JOUR
TI  - Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.
AU  - Labori KJ
AU  - Bratlie SO
AU  - Andersson B
AU  - Angelsen JH
AU  - Biörserud C
AU  - Björnsson B
AU  - Bringeland EA
AU  - Elander N
AU  - Garresori H
AU  - Grønbech JE
AU  - Haux J
AU  - Hemmingsson O
AU  - Liljefors MG
AU  - Myklebust TÅ
AU  - Nymo LS
AU  - Peltola K
AU  - Pfeiffer P
AU  - Sallinen V
AU  - Sandström P
AU  - Sparrelid E
AU  - Stenvold H
AU  - Søreide K
AU  - Tingstedt B
AU  - Verbeke C
AU  - Öhlund D
AU  - Klint L
AU  - Dueland S
AU  - Lassen K
AU  - Nordic Pancreatic Cancer Trial-1 study group
PY  - 2024
JO  - The lancet. Gastroenterology & hepatology
DO  - 10.1016/s2468-1253(23)00405-3
UR  - https://doi.org/10.1016/s2468-1253(23)00405-3
ER  -

APA

KJ, L., SO, B., B, A., JH, A., C, B., B, B., EA, B., N, E., H, G., JE, G., J, H., O, H., MG, L., TÅ, M., LS, N., K, P., P, P., V, S., P, S., E, S., H, S., K, S., B, T., C, V., D, Ö., L, K., S, D., K, L., & group, N. P. C. T. S. (2024). Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.. The lancet. Gastroenterology & hepatology. https://doi.org/10.1016/s2468-1253(23)00405-3

Source records

pubmed · retrieved 2026-09-25T22:53:22.069Z